Ex-Stryker Sales Rep Pleads Guilty To Misbranding

Law360, New York (February 20, 2009, 12:00 AM EST) -- A former sales representative for Stryker Corp. has pled guilty to felony misbranding charges for promoting bone growth products for purposes not approved by the U.S. Food and Drug Administration.

Justin Demming, 32, of Ohio pled guilty to the charges on Feb. 10 before Judge Nancy Gertner of the U.S. District Court for the District of Massachusetts, facing a maximum sentence of three years in prison and one year of supervised release. He could also be forced to pay a $250,000 fine. Demming is set to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.